| # | Drug | Count |
|---|---|---|
| 0 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 2 |
| 1 | CYTARABINE | 2 |
| 2 | ATEZOLIZUMAB | 1 |
| 3 | AZACITIDINE | 1 |
| 4 | AZACITIDINE FOR | 1 |
| 5 | BEVACIZUMAB | 1 |
| 6 | CARBOPLATIN | 1 |
| 7 | CASPOFUNGIN ACETATE | 1 |
| 8 | ITRACONAZOLE | 1 |
| 9 | PEMBROLIZUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 2 | 0.0008 |
| 1 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 3 | ITRACONAZOLE | 1 | 0.0001 |
| 4 | AZACITIDINE | 1 | 0.0000 |
| 5 | CYTARABINE | 2 | 0.0000 |
| 6 | PEMETREXED DISODIUM | 1 | 0.0000 |
| 7 | ATEZOLIZUMAB | 1 | 0.0000 |
| 8 | VENETOCLAX | 1 | 0.0000 |
| 9 | PEMBROLIZUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 2 | 0.0008 |
| 1 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 1 | 0.0000 |